By Professor Glenda Halliday

Journal articles

Surmeier DJ; Halliday GM; Simuni T, 2017, 'Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease', Experimental Neurology, 298, pp. 202 - 209, http://dx.doi.org/10.1016/j.expneurol.2017.08.001

Taskesen E; Mishra A; van der Sluis S; Ferrari R; Veldink JH; van Es MA; Smit AB; Posthuma D; Pijnenburg Y; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Albani D; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Waldö ML; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; St George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; van der Zee J; Van Broeckhoven C; Cappa SF; Leber I; Hannequin D; Golfier V; Vercelletto M; Brice A; Nacmias B; Sorbi S; Bagnoli S; Piaceri I; Nielsen JE; Hjermind LE; Riemenschneider M; Mayhaus M, 2017, 'Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS', Scientific Reports, 7, pp. 8899, http://dx.doi.org/10.1038/s41598-017-09320-z

Halliday G, 2017, 'Pathology and hippocampal atrophy in Alzheimer's disease', The Lancet Neurology, 16, pp. 862 - 864, http://dx.doi.org/10.1016/S1474-4422(17)30343-5

Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM, 2017, 'Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis', Acta neuropathologica communications, 5, pp. 76, http://dx.doi.org/10.1186/s40478-017-0480-2

James Surmeier D; Obeso JA; Halliday GM, 2017, 'Parkinson’s disease is not simply a prion disorder', Journal of Neuroscience, 37, pp. 9799 - 9807, http://dx.doi.org/10.1523/JNEUROSCI.1787-16.2017

Surmeier DJ; Obeso JA; Halliday GM, 2017, 'Response from dual perspectives companion', Journal of Neuroscience, 37, pp. 9815 - 9816

Genoud S; Roberts BR; Gunn AP; Halliday GM; Lewis SJG; Ball HJ; Hare DJ; Double KL, 2017, 'Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain', Metallomics, 9, pp. 1447 - 1455, http://dx.doi.org/10.1039/c7mt00244k

Hsiao JHT; Halliday GM; Kim WS; Hsiao J-H, 2017, 'α-Synuclein regulates neuronal cholesterol efflux', Molecules, 22, pp. 1769, http://dx.doi.org/10.3390/molecules22101769

Obeso JA; Stamelou M; Goetz CG; Poewe W; Lang AE; Weintraub D; Burn D; Halliday GM; Bezard E; Przedborski S; Lehericy S; Brooks DJ; Rothwell JC; Hallett M; DeLong MR; Marras C; Tanner CM; Ross GW; Langston JW; Klein C; Bonifati V; Jankovic J; Lozano AM; Deuschl G; Bergman H; Tolosa E; Rodriguez-Violante M; Fahn S; Postuma RB; Berg D; Marek K; Standaert DG; Surmeier DJ; Olanow CW; Kordower JH; Calabresi P; Schapira AHV; Stoessl AJ, 2017, 'Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy', Movement Disorders, 32, pp. 1264 - 1310, http://dx.doi.org/10.1002/mds.27115

Weissleder C; Kondo MA; Yang C; Fung SJ; Rothmond DA; Wong MW; Halliday GM; Herman MM; Kleinman JE; Webster MJ; Shannon Weickert C, 2017, 'Early-life decline in neurogenesis markers and age-related changes of TrkB splice variant expression in the human subependymal zone', European Journal of Neuroscience, 46, pp. 1768 - 1778, http://dx.doi.org/10.1111/ejn.13623

McKeith IG; Boeve BF; Dickson DW; Halliday G; Taylor JP; Weintraub D; Aarsland D; Galvin J; Attems J; Ballard CG; Bayston A; Beach TG; Blanc F; Bohnen N; Bonanni L; Bras J; Brundin P; Burn D; Chen-Plotkin A; Duda JE; El-Agnaf O; Feldman H; Ferman TJ; Ffytche D; Fujishiro H; Galasko D; Goldman JG; Gomperts SN; Graff-Radford NR; Honig LS; Iranzo A; Kantarci K; Kaufer D; Kukull W; Lee VMY; Leverenz JB; Lewis S; Lippa C; Lunde A; Masellis M; Masliah E; McLean P; Mollenhauer B; Montine TJ; Moreno E; Mori E; Murray M; O'Brien JT; Orimo S; Postuma RB; Ramaswamy S; Ross OA; Salmon DP; Singleton A; Taylor A; Thomas A; Tiraboschi P; Toledo JB; Trojanowski JQ; Tsuang D; Walker Z; Yamada M; Kosaka K, 2017, 'Diagnosis and management of dementia with Lewy bodies', Neurology, 89, pp. 88 - 100, http://dx.doi.org/10.1212/WNL.0000000000004058

Szeto JYY; Halliday GM; Naismith SL; Lewis SJG, 2017, 'Exploring the Phenotype in Mild Cognitive Impairment to Aid the Prediction of Those at Risk of Transitioning to Parkinson Disease and Dementia with Lewy Bodies', Journal of Geriatric Psychiatry and Neurology, 30, pp. 196 - 205, http://dx.doi.org/10.1177/0891988717711451

Kovacs GG; Xie SX; Lee EB; Robinson JL; Caswell C; Irwin DJ; Toledo JB; Johnson VE; Smith DH; Alafuzoff I; Attems J; Bencze J; Bieniek KF; Bigio EH; Bodi I; Budka H; Dickson DW; Dugger BN; Duyckaerts C; Ferrer I; Forrest SL; Gelpi E; Gentleman SM; Giaccone G; Grinberg LT; Halliday GM; Hatanpaa KJ; Hof PR; Hofer M; Hortobágyi T; Ironside JW; King A; Kofler J; Kövari E; Kril JJ; Love S; Mackenzie IR; Mao Q; Matej R; McLean C; Munoz DG; Murray ME; Neltner J; Nelson PT; Ritchie D; Rodriguez RD; Rohan Z; Rozemuller A; Sakai K; Schultz C; Seilhean D; Smith V; Tacik P; Takahashi H; Takao M; Thal DR; Weis S; Wharton SB; White CL; Woulfe JM; Yamada M; Trojanowski JQ, 2017, 'Multisite assessment of aging-related tau astrogliopathy (ARTAG)', Journal of Neuropathology and Experimental Neurology, 76, pp. 605 - 619, http://dx.doi.org/10.1093/jnen/nlx041

Silsby M; Tweedie-Cullen RY; Murray CR; Halliday GM; Hodges JR; Burrell JR, 2017, 'The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias', European Journal of Neurology, 24, pp. 956 - 965, http://dx.doi.org/10.1111/ene.13314

Trist BG; Davies KM; Cottam V; Genoud S; Ortega R; Roudeau S; Carmona A; De Silva K; Wasinger V; Lewis SJG; Sachdev PS; Smith B; Troakes C; Vance C; Shaw C; Al-Sarraj S; Ball HJ; Halliday GM; Hare DJ; Double KL, 2017, 'Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson's disease brain', Acta Neuropathologica, http://dx.doi.org/10.1007/s00401-017-1726-6

Bodea LG; Evans HT; Van der Jeugd A; Ittner LM; Delerue F; Kril J; Halliday G; Hodges J; Kiernan MC; Götz J, 2017, 'Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model', Aging Cell, 16, pp. 377 - 386, http://dx.doi.org/10.1111/acel.12565

Poewe W; Seppi K; Tanner CM; Halliday GM; Brundin P; Volkmann J; Schrag AE; Lang AE, 2017, 'Parkinson disease', Nature Reviews Disease Primers, 3, pp. 1 - 21, http://dx.doi.org/10.1038/nrdp.2017.13

Yang Y; Shepherd CE; Halliday GM, 2017, 'Increased aneuploidy is not a universal feature across α-synucleinopathies', Movement Disorders, 32, pp. 475 - 476, http://dx.doi.org/10.1002/mds.26869

Dzamko N; Gysbers AM; Bandopadhyay R; Bolliger MF; Uchino A; Zhao Y; Takao M; Wauters S; van de Berg WDJ; Takahashi-Fujigasaki J; Nichols RJ; Holton JL; Murayama S; Halliday GM, 2017, 'LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies', Movement Disorders, 32, pp. 423 - 432, http://dx.doi.org/10.1002/mds.26892

Ahmed RM; Irish M; van Eersel J; Ittner A; Ke YD; Volkerling A; van der Hoven J; Tanaka K; Karl T; Kassiou M; Kril JJ; Piguet O; Götz J; Kiernan MC; Halliday GM; Hodges JR; Ittner LM, 2017, 'Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology', Neuroscience and Biobehavioral Reviews, 74, pp. 126 - 138, http://dx.doi.org/10.1016/j.neubiorev.2017.01.004

Tan RH; Ke YD; Ittner LM; Halliday GM, 2017, 'ALS/FTLD: experimental models and reality', Acta Neuropathologica, 133, pp. 177 - 196, http://dx.doi.org/10.1007/s00401-016-1666-6

Damian DL; Martin AJ; Scolyer RA; Chen AC; Halliday GM, 2017, 'Authors' response to a reply to ‘A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients’', British Journal of Dermatology, 176, pp. 552 - 553, http://dx.doi.org/10.1111/bjd.15204

Ferrari R; Wang Y; Vandrovcova J; Guelfi S; Witeolar A; Karch CM; Schork AJ; Fan CC; Brewer JB; Momeni P; Schellenberg GD; Dillon WP; Sugrue LP; Hess CP; Yokoyama JS; Bonham LW; Rabinovici GD; Miller BL; Andreassen OA; Dale AM; Hardy J; Desikan RS; Ferrari R; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Albani D; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Landqvist Waldö M; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; St George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; van der Zee J; Cruts M, 2017, 'Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases', Journal of Neurology, Neurosurgery and Psychiatry, 88, pp. 152 - 164, http://dx.doi.org/10.1136/jnnp-2016-314411

Surmeier DJ; Obeso JA; Halliday GM, 2017, 'Selective neuronal vulnerability in Parkinson disease', Nature Reviews Neuroscience, 18, pp. 101 - 113, http://dx.doi.org/10.1038/nrn.2016.178

Dzamko N; Gysbers A; Perera G; Bahar A; Shankar A; Gao J; Fu YH; Halliday GM, 2017, 'Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology', Acta Neuropathologica, 133, pp. 303 - 319, http://dx.doi.org/10.1007/s00401-016-1648-8

Kun-Rodrigues C; Ross OA; Orme T; Shepherd C; Parkkinen L; Darwent L; Hernandez D; Ansorge O; Clark LN; Honig LS; Marder K; Lemstra A; Scheltens P; van der Flier W; Louwersheimer E; Holstege H; Rogaeva E; St. George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Maetzler W; Berg D; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Trojanowski JQ; Serrano GE; Beach TG; Clarimon J; Lleó A; Morenas-Rodríguez E; Lesage S; Galasko D; Masliah E; Santana I; Diez M; Pastor P; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Stone DJ; Pickering-Brown S; Mann D; Dickson DW; Halliday GM; Singleton A; Guerreiro R; Bras J, 2017, 'Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies', Neurobiology of Aging, 49, pp. 214.e13 - 214.e15, http://dx.doi.org/10.1016/j.neurobiolaging.2016.08.023

Burrell JR; Ballard KJ; Halliday GM; Hodges JR, 2017, 'Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia', Journal of Alzheimer's Disease, 61, pp. 705 - 715, http://dx.doi.org/10.3233/JAD-170743

Tan RH; Kril JJ; Yang Y; Tom N; Hodges JR; Villemagne VL; Rowe CC; Leyton CE; Kwok JBJ; Ittner LM; Halliday GM, 2017, 'Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 9, pp. 10 - 20, http://dx.doi.org/10.1016/j.dadm.2017.05.005

Bhatia S; Fu YH; Hsiao JHT; Halliday GM; Kim WS, 2017, 'Deletion of Alzheimer's Disease Risk Gene ABCA7 Alters White Adipose Tissue Development and Leptin Levels', Journal of Alzheimer's Disease Reports, 1, pp. 237 - 247, http://dx.doi.org/10.3233/ADR-170029

Kirik D; Cederfjäll E; Halliday G; Petersén , 2017, 'Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands', Neurobiology of Disease, 97, pp. 179 - 188, http://dx.doi.org/10.1016/j.nbd.2016.09.008

Ahmed RM; Highton-Williamson E; Caga J; Thornton N; Ramsey E; Zoing M; Kim WS; Halliday GM; Piguet O; Hodges JR; Farooqi IS; Kiernan MC, 2017, 'Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition', Journal of Alzheimer's Disease, 61, pp. 773 - 783, http://dx.doi.org/10.3233/JAD-170660

Van Langenhove T; Piguet O; Burrell JR; Leyton C; Foxe D; Abela M; Bartley L; Kim WS; Jary E; Huang Y; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR, 2017, 'Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia', Journal of Alzheimer's Disease, 58, pp. 163 - 170, http://dx.doi.org/10.3233/JAD-161272

Purves-Tyson TD; Owens SJ; Rothmond DA; Halliday GM; Double KL; Stevens J; McCrossin T; Shannon Weickert C, 2017, 'Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain', Translational Psychiatry, 7, pp. e1003 - e1003, http://dx.doi.org/10.1038/tp.2016.257

Kordower JH; Goetz CG; Chu Y; Halliday GM; Nicholson DA; Musial TF; Marmion DJ; Stoessl AJ; Sossi V; Freeman TB; Olanow CW, 2017, 'Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient', Annals of Neurology, 81, pp. 46 - 57, http://dx.doi.org/10.1002/ana.24820

Devenney EM; Landin-Romero R; Irish M; Hornberger M; Mioshi E; Halliday GM; Kiernan MC; Hodges JR, 2017, 'The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion', NeuroImage: Clinical, 13, pp. 439 - 445, http://dx.doi.org/10.1016/j.nicl.2016.11.028

Yang Y; Halliday GM; Hodges JR; Tan RH, 2017, 'Von Economo Neuron Density and Thalamus Volumes in Behavioral Deficits in Frontotemporal Dementia Cases with and without a C9ORF72 Repeat Expansion', Journal of Alzheimer's Disease, 58, pp. 701 - 709, http://dx.doi.org/10.3233/JAD-170002

Halliday GM, 2017, '[S3–01–01]: MIXED PATHOLOGY IN ALZHEIMER's DISEASE', Alzheimer's & Dementia, 13, http://dx.doi.org/10.1016/j.jalz.2017.07.254

Chen AC; Martin AJ; Dalziell RA; Halliday GM; Damian DL, 2016, 'Oral nicotinamide reduces transepidermal water loss: a randomized controlled trial', British Journal of Dermatology, 175, pp. 1363 - 1365, http://dx.doi.org/10.1111/bjd.14648

Weissleder C; Fung SJ; Wong MW; Barry G; Double KL; Halliday GM; Webster MJ; Weickert CS, 2016, 'Decline in proliferation and immature neuron markers in the human subependymal zone during aging: Relationship to EGF- and FGF-related transcripts', Frontiers in Aging Neuroscience, 8, pp. 274, http://dx.doi.org/10.3389/fnagi.2016.00274

Hu YB; Zou Y; Huang Y; Zhang YF; Lourenco GF; Chen SD; Halliday GM; Wang G; Ren RJ, 2016, 'ROCK1 is associated with Alzheimer’s disease-specific plaques, as well as enhances autophagosome formation but not autophagic Aβ clearance', Frontiers in Cellular Neuroscience, 10, http://dx.doi.org/10.3389/fncel.2016.00253

Postuma RB; Berg D; Stern M; Poewe W; Olanow CW; Oertel W; Marek K; Litvan I; Lang AE; Halliday G; Goetz CG; Gasser T; Dubois B; Chan P; Bloem BR; Adler CH; Deuschl G, 2016, 'Abolishing the 1-year rule: How much evidence will be enough?', Movement Disorders, 31, pp. 1623 - 1627, http://dx.doi.org/10.1002/mds.26796

Chen BJ; Mills JD; Takenaka K; Bliim N; Halliday GM; Janitz M, 2016, 'Characterization of circular RNAs landscape in multiple system atrophy brain', Journal of Neurochemistry, 139, pp. 485 - 496, http://dx.doi.org/10.1111/jnc.13752

Ahmed RM; Devenney EM; Irish M; Ittner A; Naismith S; Ittner LM; Rohrer JD; Halliday GM; Eisen A; Hodges JR; Kiernan MC, 2016, 'Neuronal network disintegration: Common pathways linking neurodegenerative diseases', Journal of Neurology, Neurosurgery and Psychiatry, 87, pp. 1234 - 1241, http://dx.doi.org/10.1136/jnnp-2014-308350

Guerreiro R; Escott-Price V; Darwent L; Parkkinen L; Ansorge O; Hernandez DG; Nalls MA; Clark L; Honig L; Marder K; van der Flier W; Holstege H; Louwersheimer E; Lemstra A; Scheltens P; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Ortega-Cubero S; Pastor P; Ferman TJ; Graff-Radford NR; Ross OA; Barber I; Braae A; Brown K; Morgan K; Maetzler W; Berg D; Troakes C; Al-Sarraj S; Lashley T; Compta Y; Revesz T; Lees A; Cairns NJ; Halliday GM; Mann D; Pickering-Brown S; Powell J; Lunnon K; Lupton MK; Dickson D; Hardy J; Singleton A; Bras J, 2016, 'Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases', Neurobiology of Aging, 38, pp. 214.e7 - 214.e10, http://dx.doi.org/10.1016/j.neurobiolaging.2015.10.028

Fu YH; Paxinos G; Watson C; Halliday GM, 2016, 'The substantia nigra and ventral tegmental dopaminergic neurons from development to degeneration', Journal of Chemical Neuroanatomy, 76, pp. 98 - 107, http://dx.doi.org/10.1016/j.jchemneu.2016.02.001

Perera G; Ranola M; Rowe DB; Halliday GM; Dzamko N, 2016, 'Inhibitor treatment of peripheral mononuclear cells from Parkinson's disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker', Scientific Reports, 6, http://dx.doi.org/10.1038/srep31391

Fu Y; Hsiao JHT; Paxinos G; Halliday GM; Kim WS, 2016, 'ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain', Journal of Alzheimer's Disease, 54, pp. 569 - 584, http://dx.doi.org/10.3233/JAD-160456

Burrell JR; Halliday GM; Kril JJ; Ittner LM; Götz J; Kiernan MC; Hodges JR, 2016, 'The frontotemporal dementia-motor neuron disease continuum', The Lancet, 388, pp. 919 - 931, http://dx.doi.org/10.1016/S0140-6736(16)00737-6

Landeck N; Hall H; Ardah MT; Majbour NK; El-Agnaf OMA; Halliday G; Kirik D, 2016, 'A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein', Molecular Neurodegeneration, 11, http://dx.doi.org/10.1186/s13024-016-0125-0

Shibuya K; Park SB; Geevasinga N; Menon P; Howells J; Simon NG; Huynh W; Noto YI; Götz J; Kril JJ; Ittner LM; Hodges J; Halliday G; Vucic S; Kiernan MC, 2016, 'Motor cortical function determines prognosis in sporadic ALS', Neurology, 87, pp. 513 - 520, http://dx.doi.org/10.1212/WNL.0000000000002912

Back to profile page